摘要
目的探讨异基因造血干细胞移植(allo-HSCT)后共刺激分子LIGHT和HVEM的表达与移植物抗宿主病(GVHD)发生的关系。方法26例allo-HSCT患者中,预处理方案采用环磷酰胺+足叶乙甙+全身照射11例,采用氟达拉滨+阿糖胞苷+白消安12例,采用环磷酰胺3例。移植时,输注单个核细胞(5.89±3.36)×10^8/kg,CD34^+细胞(3.29±1.29)×10^6/kg。预防急性GVHD(aGVHD)的方案采用环孢素A+短程甲氨蝶呤+吗替麦考酚酯,HLA半相合及非血缘关系者加用抗胸腺细胞球蛋白。GVHD的诊断与分级采用西雅图标准。在预处理前、移植后15d、发生aGVHD时及aGVHD经治疗好转后分别采集患者外周血2ml,采用三色流式细胞术进行检测,同时以15名健康志愿者的血液标本作为正常对照。结果所有患者均获得造血功能重建,移植物均完全植活。移植后共发生aGVHD9例,发生率为35%,其中Ⅲ~Ⅳ度者3例,8例经治疗后好转,1例治疗无效死亡;发生慢性GVHD(cGVHD)7例,发生率为26.9%。患者预处理前和移植后15d及正常人外周血T淋巴细胞几乎不表达LIGHT,组成性表达HVEM;发生GVHD时,LIGHT表达显著上调,HVEM表达下调;GVHD好转后,LIGHT和HVEM的表达恢复正常。移植后158时,发生aGVHD者LIGHT的表达高于未发生aGVHD者,而HVEM的表达较低(P〈0.05)。Ⅲ~Ⅳ度aGVHD者LIGHT的表达明显高于I~II度者(P〈0.05)。结论LIGHT/HVEM在allo-HSCT后GVHD的发生和发展过程中起重要作用,通过监测该共刺激分子的表达对aGVHD的发生有一定预示作用。
Objective To explore the relationship between the expression of LIGHT/HVEM in patients after allo-HSCT and the development of GVHD. Methods The expression of LIGHT and HVEM in T lymphocytes was detected by FACS Calibur. Results All patients achieved engraftment and hematopoiesis reconstitution, aGVHD occurred in 9 of 26 patients (34. 6 %) with grade III-IV aGVHD in 3 cases. Seven cases developed cGVHD (26. 9 % ). LIGHT was not expressed in T lymphocytes from healthy donors and patients without GVHD, while constitutive expression of HVEM was detected. When aGVHD occurred, the expression levels of LIGHT in T lymphocytes were significantly increased, while those of HVEM decreased. After GVHD was controlled, the expression levels of those co-stimulators went back to normal. On the day 15 after transplantation, the expression of LIGHT in T lymphoeytes of patients with aGVHD later was significantly higher, while that of HVEM lower than in those without aGVHD. The patients with aGVHD of grades III-IV demonstrated higher LIGHT expression than in those with aGVHD of grades I - II. Conclusion The expression of LIGHT and HVEM might be involved in the development of GVHD after aIlo-HSCT and could be used as one of the'useful indicators in predicting aGVHD.
出处
《中华器官移植杂志》
CAS
CSCD
北大核心
2010年第2期89-92,共4页
Chinese Journal of Organ Transplantation
基金
国家自然科学基金(30172347,308711002)
上海市生物医药重大科技攻关项目(05DZ19327)
关键词
造血干细胞移植
受体
肿瘤坏死因子
成员14
移植物抗宿主病
Hematopoietic stem cell transplantation
Receptors, tumor necrosis factor, member 14
Graft versus host disease